Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-000167
Filing Date
2023-01-03
Accepted
2023-01-03 16:05:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A arav20230103_defa14a.htm DEFA14A 55396
2 aravive01.jpg GRAPHIC 4272
  Complete submission text file 0001437749-23-000167.txt   62497
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36361 | Film No.: 23502089
SIC: 2834 Pharmaceutical Preparations